Search
-
[WEBINAR] Brand Hacks: Build Brands by Fulfilling The Quest for Meaning
Join us for a complimentary webinar as we share insights from Wall Street Journal bestseller Brand Hacks.
-
Buying
The future of buying will be more digital, including in social platforms and the metaverse, even as people look forward to returning to stores. Here’s what they’ll expect from retailers to make shopping and paying more enjoyable, efficient and easy.
-
Wealth
America’s aging population, growing diversity among the rich and the digital era are changing wealth and luxury in America. Ipsos imagines how these shifts will impact wealth transfer, fiscal policy, retail and luxury through crypto and the metaverse.
-
Food Channel Blurring is Today’s New Omnichannel
Discover insights to drive innovation given major behavioral changes in how we obtain, prepare and consume food.
-
[WEBINAR] The Future of Point of Care and Rapid Testing
How has the Point of Care (PoC) and rapid testing market evolved, and what does the future hold?
-
Insights For Pharma: Helping ‘Challenger’ Brands Win
Discover tips for how a “challenger” brand can make a mark, and ultimately win at launch...
-
Fewer consumers say they have changed their behavior due to climate concern than did before the pandemic
In-home behaviors top list of climate-conscious actions taken more often: recycling/composting, saving energy, saving water and avoiding food waste.
-
How can high-end brands redefine luxury shopping for the digital age?
Nearly a quarter of luxury shoppers prefer to shop online versus in-store, and nearly 4-in-10 prefer both online and in-store equally.
-
The Digital Era is Reshaping Wealth and Consumption
Ipsos research highlights Americans’ unique view of wealth and the influence that digital, diversity and the Great Wealth Transfer will have on how we pass, share, spend and invest it
-
Oncology: the disease, dynamics & challenges of market research
The oncology treatment landscape rarely stands still, and its constant evolution affects all those involved: patients, their carers, cancer treaters, and treatment manufactures.